Our Focus: 5 Cancer Types—How Many Lives Saved?
What if we could improve lung cancer screening for all people, regardless of smoking status? Or what if we found a way to identify ovarian cancer long before it became lethal? And why can’t benign breast cancer tissue be more easily identified from cancerous tissue, resulting in less worry and trauma for the patient? This is the program work done at the Canary Foundation.
Dr. Sanjiv (Sam) Gambhir discusses next-generation technologies being developed at Canary Center at Stanford
Today, our clinical programs cover tumors across five cancer types: breast, lung, ovarian, pancreatic, and prostate. As part of our approach, we pull together multidisciplinary teams that approach cancer problems in new ways. Each team works with a practicing oncologist, focusing on a specific clinical problem, and many of these teams now have ongoing clinical trials underway. They know, and we know, that identifying early stage cancers saves lives.